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Thymus-derived suppressor cells (Ts)1 regulate humoral (1, 2), cell-mediated (3, 4), 
or proliferative  (5)  responses,  and  the  characterization  of these  suppressor systems 
reveals that  there are probably several distinct  types of Ts.  This  has been  further 
complicated by the demonstration in certain systems that one Ts or another immune 
cell may help induction of other phenotypically distinct Ts (6-10). These latter studies 
have raised the possibility that various Ts may in fact be part of a larger interrelated 
network of suppressor cells (11). 
Studies  from this laboratory  (7,  8,  10)  designed  to analyze the suppressor T  cell 
network revealed that in several systems, antigen presented on syngeneic cells induces 
an  antigen-specific  I-J+  suppressor  T  cell,  Tst,  from  which  an  antigen-specific, 
idiotype  ÷, I-J+ suppressor factor, TsF1, can be obtained. TsFa, in turn, stimulates the 
development of a second set of suppressor T  cells, Ts2, which are anti-idiotypic, I-J  +, 
and which suppress antigen-specific immune cells. 
To better understand  suppressor T  cell networks we must determine what signals 
stimulate suppressor T  cells. Compared with our detailed knowledge of the I region- 
controlled requirement  for the stimulation of helper T  cells by antigen, very little is 
known of the conditions  for suppressor T  cell stimulation.  These experiments were 
designed  to  address  this  issue.  We  explored  whether  a  major  histocompatibility 
complex  (MHC)  requirement  for  the  stimulation  of suppressor  T  cells  could  be 
revealed  by administering  syngeneic spleen  cells  derivatized  with  a  low  density  of 
hapten, a stimulus which is incapable of triggering suppression unless allogeneic cells 
are added, thus demonstrating the requirement of an allogeneic effect in the devel- 
opment of suppressor T  cell responses. We then were able to verify that allogeneic T 
cells responding to I-J-coded differences on suppressor T  ceils provided the necessary 
stimulus together with antigen, at the low dose used, for the development of specific 
suppression. The significance of this finding is discussed in relation to MHC restric- 
tions in the development of suppressor T  cell responses. 
* This work was supported by National Institutes of Health grant ROIA116396. 
:~ Supported by grant GM07753-02 of the Medical Scientist Training Program. 
I Abbreviations used in  this paper: AEF, allogeneic effect factor; CS, contact sensitivity; DNFB, 2,4- 
dinitrofluorobenzene; DNP, dinitrophenyl; HBSS, Hanks' buffered saline solution; MHC, major histocom- 
patibility complex; PCI, 2,4,6-trinitrochlorobenzene (picryl  chloride); TNBS, 2,4,6-trinitrobenzene sulfonic 
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Materials  and  Methods 
Animals.  All mouse strains were  purchased  from  The Jackson  Laboratory, Bar  Harbor, 
Maine and housed in our animal facilities. 
Antigens.  2,4,6-trinitrobenzene sulfonic acid (TNBS), 2,4-dinitrofluorobenzene (DNFB), and 
2,4,6-trinitrochlorobenzene (picryl chloride, PCI) were purchased from Eastman Kodak Com- 
pany, Rochester, N. Y. 
Antiserum.  A monoclonal anti-Thy 1.2 ascitic fluid used at  I:1,000 was kindly provided by 
Dr. P. Lake, University College, London. 
TNP-derivatized Cell Preparation.  Spleen  cells were  suspended  in  chilled Hanks'  buffered 
saline solution (HBSS). Erythrocytes were lysed by treatment with 0.83% ammonium chloride 
in Tris buffer, pH  7.6.  After washing, cells were resuspended to 5  ×  107 cells/ml in  HBSS 
containing TNBS, pH 7.4 (adjusted with NaOH), at the appropriate molarity. The cells were 
incubated for 30 min at room temperature with gentle stirring. The cell suspensions were then 
washed three times with HBSS and resuspended to appropriate final concentrations. For 0.01 
mM TNBS solutions, the concentration used throughout these experiments, cell viability was 
always 50-70%. 
Generation of Suppressor Cells.  Animals were injected intravenously with 5 ×  10  v live, synge- 
neic, haptenated cells and were either immunized on the same day (nontransfer ~rotocol) or 
served as donors ofTs 7 d later (transfer protocol). In the transfer protocol, 5 ×  10  live spleen 
cells were transferred from these Ts donors to appropriate recipients that had been immunized 
1-2 h earlier. 
Immunization and Challenge.  Animals were immunized by skin painting with one 100-/zl dose 
of a  7% PCI solution or two daily doses of 25/zl of a 0.5%  DNFB solution in acetone:olive oil 
(4:1)  on the shaved abdomen. 5 d later, 20/zl of a 0.5% PCI solution or a 0.2% DNFB solution 
in acetone:olive oil was applied to both ears of the appropriately immunized animals. The 
extent of the contact sensitivity (CS) reaction is expressed as the difference in thickness of each 
ear measured with an engineer's micrometer immediately before and 24 h after challenge. All 
groups contained three to five mice and the mean and standard error of the mean (SEM) are 
depicted. P values reflect differences obtained using the Student's two-tailed t test. 
Results 
Epitope Density on Cell Surfaces Influences the Generation of Ts.  After having shown that 
high  hapten  density  (10  mM  TNBS  derivatization of tolerogen)  on  allogeneic cells 
could supersede and  abrogate  the allogeneic restrictions of Ts  for CS  (12),  we next 
asked  whether  a  very  low  density  of  hapten  (0.01  mM  TNBS  derivatization  of 
tolerogen)  on  syngeneic cells could  possibly generate  a  syngeneically restricted Ts, 
since  1 mM  derivatized allogeneic cells could  generate  allogeneically restricted Ts. 
Fig. 1 shows an experiment in which BALB/c mice received, intravenously, syngeneic 
cells haptenated at various concentrations of TNBS  (0.01-10 mM).  1 wk later, these 
animals  served  as  donors  of putative  Ts  to  either syngeneic BALB/c  recipients or 
completely allogeneic B6  recipients, which  were  all  immunized  on  the  day of cell 
transfer.  Contrary  to  our  expectations,  syngeneic Ts  were  not  induced.  In  fact,  Ts 
induced by progressively less haptenated  tolerogen functioned less well in syngeneic 
recipients  but  continued  to  manifest  a  large  degree  of suppression  in  allogeneic 
recipients. 
These results led us to conclude that a  "pre-Ts" was being generated by low (0.0t 
raM)  hapten  densities  and  that  it  required  a  second,  activating  or  differentiating 
signal which  was being provided by an  allogeneic effect. This  idea was tested more 
directly as shown in Fig. 2. Syngeneic 0.01  mM haptenated spleen cells were injected 
intravenously  into  BALB/c  recipients.  1 wk  later their  spleens  were  transferred  to 
syngeneic BALB/c recipients or allogeneic CBA/J recipients. As before, the transferred J.  s.  BROMBERG,  B.  BENACERRAF, AND  M.  I. GREENE  439 
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F~c.  l.  Hapten  density and allogeneic effects on the generation of suppressor cells. 5 X  107 10 
mM, 1 raM, 0.1 mM, or 0.0[ mM TNBS-derivatized BALB/e cells were injected intravenously into 
syngeneic recipients. 7 d later, 5 x  10  v spleen cells from these groups of mice were transferred into 
syngeneic or allogeneic (C57BL/6) recipients, which were then immunized epicutaneously with PCI. 
5 d thereafter, the separate groups were challenged on the ear with PCI, and T cell-dependent CS 
reactivity was determined 24 h later. 
cells functioned only as Ts in the allogeneic strain.  However, if an allogeneic signal is 
given  concomitantly  with  the  Ts  to  the  syngeneic  recipient,  then  suppression  is 
manifested.  Thus,  if a  BALB/c  recipient  receives  both  BALB/c Ts  and  allogeneic 
cells  (3  X  107  CBA/J  spleen  cells),  the  CS  reaction  is  suppressed.  Neither  cell 
population on its own is able to accomplish this. 
Kinetics of AUogeneic Effects Necessary for Ts t~ J..,tion.  Additional experiments reveal 
that in a  nontransfer protocol (i.e, one in whicn the recipient  of the haptenated  cells 
is tested directly for CS), haptenated syngeneic cells plus an allogeneic signal given on 
the day of abdominal  immunization will suppress the CS reaction.  Fig. 3 shows that 
if an  animal  is  both  immunized  and  given 0.01  mM  haptenated  syngeneic cells on 
day  0,  then  an  allogeneic  signal  can  be  given  from  day  -5  to  2  to  significantly 
suppress  a  challenge  on day 5.  Thus,  the  kinetics  of induction  of these Ts  is  short. 
Notably, neither haptenated cells nor allogeneic cells alone suppress the CS response. 
Although this nontransfer protocol is less cumbersome than the transfer protocol, we 
have  decided  to  pursue  the  latter  because  it  permits  one  to  deliver  two  unlinked 
signals  (antigen  and  allogeneic effect)  separated  by time  (7  d),  and  to dissect  more 
fully the stages of maturation  and differentiation  in the Ts pathway. 
Specificity  of Suppressor Cells.  To evaluate  whether  ligand-activated  presuppressor 
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Fig.  2.  Allogeneic effects on the generation of  suppressor  cells. 5 X 107 0.01 mM TNBS-derivatized 
BALB/c cells  were injected intravenously into syngeneic recipients.  7 d  later,  5 X  10  ~ spleen cells 
from these groups of mice were transferred into syngeneic or allogeneic (CBA/J) recipients, which 
were then immunized epicutaneously with PC1. Some syngeneic recipients also received  3  X  107 
CBA/J  cells.  5  d  later,  the  separate  groups were challenged  on  the  ear  with  PCI,  and  T  cell- 
dependent CS reactivity was determined 24 h later.  Normal BALB/c refers to donors that did not 
receive  derivatized cells. 
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FIG.  3.  Kinetics  of allogeneic  effect  with  respect  to  Ts  induction.  5  X  10  7  0.01 mM  TNBS- 
derivatized A/J ceils were injected intravenously into syngeneic recipients, which were immunized 
epicutaneously with  PCI on  the same day.  At  various times before or after  immunization, these 
animals also received  3 x  107 allogeneic (C57BL/6) cells intravenously. 5 d after immunization the 
separate  groups were challenged  on  the  ear  with  PCI,  and  T  cell-dependent  CS  reactivity  was 
determined 24 h later. j.  s.  BROMBERG,  B.  BENACERRAF, AND  M.  I.  GREENE  441 
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FIO.  4.  Antigenic specificity  of suppression.  5  x  l0 7  0.01 mM TNBS-derivatized BALB/c cells 
were injected intravenously into syngeneic  recipients.  7 d  later,  5  X  10  7 spleen cells from these 
groups of mice were transferred into allogeneic  (AKR/J) recipients, which were then immunized 
epicutaneously with PCI or DNFB.  5 d later, the separate groups were challenged on the ear with 
PCI or DNFB, and T cell-dependent CS reactivity was determined 24 h later. 
TS 
Grou9  (BALB/c)  Treatment  Immunization I  C57BI/lO 
I  Recipients 
,  _  _  +  liiiiiiiiiiiiiiiiiiiii ii :iiii j iiiiiiii iiiiiiiiii ii ii  
11  Norma I 
_  +  lii ii iiiiiiiiiiiii!iiii!iii!!iii!i!i ii  i iiii iiiiiiiiiiiiiiiiii i  BALBIc 
I11  +  --  + 
++ An.-O+C'.MS+C,  ++   Iiiiiiiiiiiiiiii!iiiiiiiiiiiii iiiiiii  
7I  --  --  --  ~ 
I  1  I 
0  5  10 
EAR SWELL/NG 
Ix/O-Zmm-+SEM) 
Rc.  5.  T  cell  nature of suppression.  5  X  107  0.01 mM  TNBS-derivatized BALB/c cells were 
injected intravenously into syngeneic recipients.  7 d later, 5 X  l0 7 spleen cells from these groups of 
mice were transferred into allogeneic  (C57BL/6)  recipients after no treatment or after treatment 
with  normal  mouse  serum  or  a  monoclonal  anti-Thy  1.2  plus  complement. The  mice  were 
immunized epicutaneously with PCI and 5 d  later were challenged on the ear with PCI;  T  cell- 
dependent CS reactivity was determined 24 h later. Normal BALB/c refers to donors that did not 
receive derivatized cells. 
were performed. 0.01  mM  TNP-derivatized BALB/c  cells were used to induce pre-Ts 
in  syngeneic recipients.  7  d  later,  these cells were  transferred  into AKR  recipients 
which were then immunized  epicutaneously with PCI or DNFB  and challenged 5  d 
later with the homologous hapten. As depicted in Fig. 4, such ligand-activated and 
atlogeneic effect-influenced  presuppresor cells function in an antigen-specific manner. 
T  Cell Nature of Suppression.  It was experimentally determined  that  such suppres- 442  MECHANISMS OF REGULATION OF CELL-MEDIATED IMMUNITY 
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F~c. 6.  Dose  dependence of allogeneic effect. 5 X 10  v 0.01 mM TNBS-derivatized  BALB/c cells 
were injected  intravenously  into  syngeneic recipients.  7 d  later, 5 X  10  7 spleen cells from these 
groups of mice were transferred into syngeneic recipients along with varying numbers (103-3 X 10  ~) 
of allogeneic (C57BL/6) cells and then immunized epicutaneously with PCI. 5 d later the separate 
groups were challenged on the ear with PCI, and T cell-dependent CS reactivity was determined 24 
h tater. 
sion was  mediated by  thymus-derived cells by inducing  presuppressors  in  BALB/c 
mice  and  treating  aliquots  of  these  cells  in  vitro  with  monoclonal  anti-Thy  1.2 
and  complement  or  normal  serum  and  complement  before  transfer  to  allogeneic 
C57BL/10 recipients. As is depicted in Fig. 5, antigen-specific T  cells are responsible 
for the observed effects. These results do not, however, exclude a  role for B cells and/ 
or macrophages which  could be crucial for idiotypic signals and  antigen-presenting 
function, respectively. 
Dose Dependence of Allogeneic Effects.  We  next  evaluated  whether  the  allogeneic 
signals  required  to  trigger preTs---*Ts differentiation  or  activation  were  dependent 
upon the dose of alloantigenic stimuli. We used constant numbers of pre-Ts induced 
in  BALB/c  which  were  transferred  into  syngeneic  recipients  at  the  same  time  as 
varying  numbers  of allogeneic cells  (Fig.  6).  The  observed  dose dependence  of the 
resultant  suppression clearly reflects the requirement  of defined allogeneic effects to 
activate or cause the differentiation of pre-Ts to Ts. We have continued to use 3 X  107 
allogeneic cells for those experiments in which the Ts and recipient are syngeneic. 
It  should  be  noted  here  that  because  all these  experiments  involve some  sort  of 
allogeneic transfer we do see some variability in responses that we attribute to antigen- 
nonspecific allogeneic effects. Thus,  in about  10-15% of our experiments, the alloge- 
neic controls are unacceptably suppressed, masking specific suppression by Ts. This 
variability has been reported by others (13). 
Mapping of the Direction of the Atlogeneic Effect.  In all of the above-mentioned studies, 
allogeneic effects were  bidirectional between  the pre-Ts  and  the  allogeneic cells or 
allogeneic recipients. To determine which effect was sufficient for activating pre-Ts, 
the following sets of experiments were undertaken. As shown  in Fig. 7A, pre-Ts were 
induced in C57BL/6 mice and then transferred into (C57BL/6  x  DBA/2)F~ mice. In 
this case, suppression did not occur.  However, if B10.D2  allogeneic cells were added J.  s.  BROMBERG, B.  BENACERRAF, AND M.  I. GREENE 
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Flo.  7.  Direction  of the allogeneic  effect. 5 ×  107 0.01 mM TNBS-derivatized C57BL/6 (A) (top) 
or (C57BL/6 X A/J)F] (B) (bottom) cells were injected intravenously into syngeneic  recipients. 7 d 
later 5 x  107 spleen cells from these groups of mice were transferred into semisyngeneic  (C57BL/6 
× DBA/2)Fj (A) or parental A/J (B) recipients. In A, 3 X 107 allogeneic (BI0.D2) cells were also 
transferred to some groups. Recipients were then immunized epicutaneously with PCI and 5 d later 
challenged on the ear with PCI; T cell-dependent CS reactivity was determined 24 h later. B also 
shows the results of another monoclonal anti-Thy 1.2 experiment. Normal B6 and normal Fl refer 
to donors that did not receive derivatized ceils. 
simultaneously with the B6 pre-Ts, then suppression was observed. This experiment 
demonstrates that the allogeneic effect must at  least be directed against the pre-Ts. 
Nevertheless, bidirectional allogeneic influences could account  for  the  suppression. 
These experiments were then extended to evaluate the impact of Fa pre-Ts given to 
a parental recipient as shown in Fig. 7B.  (C57BL/6 X A/J)F1 pre-Ts administered to 
A/J recipients resulted in suppression. These experiments unequivocally demonstrate 
that an allogeneic effect directed solely against the pre-Ts is necessary and sufficient 
to activate or differentiate such cells into those capable of suppressing T  cell immunity. 
Gene Regions Responsible for Allogeneic Effects That Influence Pre-Ts Function.  Mapping 
of the region(s) of the H-2 complex that are responsible for the allogeneic effect we 
have observed is shown in Fig. 8. Panel A maps the region to the left side of H-2 and 
panel B  maps the effect precisely to the I-J subregion. It should be noted that even 
though the A/J recipients that received B10.A(5R) cells alone were slightly nonspe- 444  MECHANISMS  OF  REGULATION  OF  CELL-MEDIATED  IMMUNITY 
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FIG.  8.  Genetics of allogeneic effect. (A)  (top) 5 ×  107 0.0t  mM TNBS-derivatized A/J cells were 
injected intravenously into syngeneic recipients. 7 d  later 5 x  10  T spleen cells from these groups of 
mice or from normal mice were transferred into B10.D2, BI0.BR, B10.A(2R), and A/J recipients. 
Recipients were immunized epicutaneously with TNCB, and 5 d  later challenged on the ear with 
PCI; T  cell-dependent CS reactivity was measured 24 h later. (B) (bottom) 5 X  10  7 0.01 mM TNBS- 
derivatized A/J cells were injected intravenously into syngeneic recipients. 7 d  later, 5 X  107 spleen 
cells from these groups of mice were transferred into A/J recipients along with 3 ×  107 BI0.A(3R) 
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cifically suppressed, those that received A/J Ts plus B 10.A(5R) cells were not at all 
suppressed.  Since A/J and B10.BR differ at the Mls locus, the data also rule out a 
contribution  to  the  allogeneic  effect  by  Mls  differences  in  this  particular  strain 
combination. In the course of these studies, we used strains mostly of the b, d, and k 
haplotypes and were able to provide a suitable allogeneic, activational signal in all six 
possible stimulator-responder strain combinations. 
Discussion 
We have been studying how MHC-derived molecules and antigen may influence 
the induction and specificity of Ts to contact sensitivity. Others have shown (3), and 
we  have  confirmed  (12),  that  haptenated  lymphoid  ceils  injected  intravenously 
generate antigen-specific Ts whose specificity for antigen plus I-I-2 is regulated by the 
genotype of the haptenated donor cell. Thus, dinitrophenyl (DNP)-conjugated cells, 
when injected into a syngeneic strain, will generate Ts that may be transferred to any 
other strain regardless of H-2 type. Miller (14) has obtained evidence that this is due 
to polyclonal expansion of Ts subsets specific for DNP plus various H-2 specificities. 
In contrast, intravenous injection ofhaptenated cells into an allogeneic strain generates 
Ts that may he successfully transferred only to strains bearing the same H-2 type as 
the original haptenated inoculum. However, in the TNP system we showed (12) that 
this  apparent  I-I-2 restriction was  dependent  on  antigen  density:  derivatization of 
lymphoid cells with higher concentrations of hapten resulted in a  tolerogen capable 
of inducing unrestricted Ts in allogeneic strains.  Hence, lymphoid cells haptenated 
with  1 mM TNBS could induce allogeneically restricted Ts, whereas  10 mM deriva- 
tized  cells  induced  unrestricted  Ts.  The  implications  of this  finding  for  antigen 
reprocessing, critical haptenization of cell surface determinants,  and/or changes in 
receptor affinity and specificity of the Ts were discussed at that time. 
We have continued our studies of the effect of hapten density on the induction and 
functional specificity of  Ts. The present results show that a suboptimal dose of antigen 
(0.01  mM TNBS-derivatized lymphoid cells) is able to induce a T  cell which requires 
a  second, activational signal  to fully express its  suppressive potential.  This second 
signal can be provided by an I-J allogeneic effect directed solely against the induced 
T  cell.  The  allogeneic effect has  traditionally  been  viewed  as  an  activational  or 
differentiation signal which, although delivered in a  nonphysiologic manner (across 
allogeneic barriers), is a reflection of normal physiologic processes and signals in the 
intact animal  (13,  15,  16).  In the best-studied allogeneic effect systems, it has been 
shown  that  an  allogeneic  Ly  1  +  T  cell  responds  to  stimulator  alloantigens  and 
produces a factor which bears those antigens and binds to and is genetically restricted 
to help B cells syngeneic to the stimulators (17,  18). How the allogeneic effect factor 
(AEF) works and what constitutes the molecule are unknown.  However, in view of 
our presently described experiments, and the recent data of Delovitch et al. (19), we 
would like to suggest that the factor bears a binding site (idiotype) for the stimulator 
molecule(s). Such an idiotypic specificity would explain the genetic restriction of the 
factor. If the AEF is  polyvalent, then an explanation is also provided for why the 
factor both hears alloantigcn and is  genetically restricted to that  alloantigcn.  This 
implies that alloantigen may not be necessary for the functional activity of AEF. The 
AEF may also bear its own "Fc" portion which endows the molecule with the ability 
to provide a differentiation signal once it has bound its target. Thus, in the experiments 446  MECHANISMS  OF  REGULATION OF CELL-MEDIATED IMMUNITY 
defined herein, AEF binds to I-J region-related molecules on pre-Ts. The binding of 
the specialized AEF molecules to such a  site on a  ligand-activated pre-Ts results in 
the  activation  or  further  differentiation  into  functional  antigen-specific  Ts.  One 
interesting implication of this line of thought is that any properly focused triggering 
event may provide a sufficient second signal for these suboptimally induced Ts. Thus 
antisera  (e.g.,  anti-I-J)  without  complement  might  provide an  appropriate  second 
signal. This may explain the results of Conlon et al.  (20)  in which an Mls allogeneic 
effect provided a potent second signal for tolerance induction to DNP CS. 
These experiments show, as demonstrated  previously (12),  that  the interaction of 
nominal  antigens  with  MHC-encoded  antigens  may have a  profound effect on  the 
generation of Ts. In the present instance, suboptimal doses and/or densities of antigen 
prime a  population  of T  cells which  are poised  to  act  as Ts.  These cells  resemble 
certain other Ts (3)  in that  they are ostensibly unrestricted once activated:  Ts may 
suppress  allogeneic  or  syngeneic  recipients  as  long as  a  proper  allogeneic  effect  is 
provided.  It is difficult to understand  how suboptimal haptenization  results in such 
a  poised cell. On the one hand, it may simply be a quantitative problem: a  low dose 
of antigen is inefficient at triggering a Ts precursor but may be able to bind enough 
receptors  to  prime  the  cell.  Alternatively,  the  problem  may be  more complex.  As 
elegantly demonstrated  by Forman et  al.  (21,  22),  the concentration  of TNBS  has 
profound effects on the derivatization of H-2 antigens and the generation of neoan- 
tigens. Higher antigen densities (1  or  10 mM) may generate a neoantigen, or altered 
self molecule, which can serve as a stimulator moiety for an allogeneic effect in vivo. 
The AEF produced by such an allogeneic effect would bind to the neoantigen. If a Ts 
precursor  had  bound  antigen  to  its  surface via its  antigen  receptor,  then  the  AEF 
could bind to the cell-associated neoantigen and deliver its signal to the precursor Ts 
through  an  antigen  bridge.  At  lower  antigen  densities  (0.01  raM),  a  Ts precursor 
could  bind  antigen  (assuming  it  is  specific  for nominal  antigen,  not  neoantigen), 
however at such low densities there is no generation  of an altered self molecule, no 
allogeneic effect, and  therefore no generation of activated Ts.  Our data  imply that 
the crucial molecule altered by TNBS treatment is I-J. 
The association of an I-J allogeneic effect with suppressor cell activation is interest- 
ing in  light  of the association of I-J with suppressor cells and  their products  (6-8). 
The recent report of Zinkernagel (23)  that an isolated I-J graft vs. host reaction may 
suppress the in vivo response to Listeria is consonant with the present data. He suggests 
that I-region molecules may act as receptors for differentiation signals. The provoca- 
tive data of Streilein  and  Klein  (24),  and  Streilein  (25)  on neonatal  tolerance may 
also involve an allogeneic host-vs.-graft response. In this case, there is strong evidence 
for associative recognition of allogeneic I-J and H-2D determinants. A model for this 
system, similar to the one above, can be constructed. One cell in the suppressor circuit 
may recognize allogeneic I-J plus  H-2D on the allograft and signal a  second cell  in 
the circuit which has bound H-2D to its surface via a specific receptor. The first cell 
recognizes allogeneic H-2D, or perhaps a complex of allogeneic H-2D, plus self I-J on 
the surface of the second cell. This model argues for a  limited polymorphism of I-J 
determinants  among  different  strains  and  supports  the  concept  that  there  is  an 
essential  association  between  recognition  of "J-ness"  and  activation  of suppressor 
circuits.  These  models  also  support  the  notion  that  restriction  (5,  6)  or  lack  of 
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pathway is initiated and what stage is being assayed in a particular protocol. Recently 
Czitrom  et  al.  (26)  have  obtained  data  similar  to  Streilein's  in  a  primary  mixed 
lymphocyte reaction. There, an I-J difference suppresses the response to allogeneic H- 
2D and  must  be associatively linked to H-2D. This raises the possibility that I-J  + Ts 
may functionally  be antigen-presenting  cells for other cells in the suppressor circuit. 
One caveat on these systems is that I-J is also associated with helper T  cell function 
and not strictly suppressor cell mechanisms (27-30). It should be noted that additional 
I subregions may be involved in certain steps of the suppressor pathway.  Sherr et al. 2 
have recently found  that  I-A and/or  I-E subregion  genes on antigen-presenting  cells 
are relevant for suppression of the reaction to protein antigens.  It may be that ligand- 
receptor interaction  requires appropriate H-2 presentation  independent  of the type of 
activation or differentiation  signals described  here. 
Perhaps the greatest implication of our findings relates to their potential application 
for enhancement  of allograft survival.  A  search for the human  equivalent  of I-J may 
prove rewarding.  In fact, the association between certain  HLA-DR  incompatibilities 
and enhanced  renal allograft survival is encouraging  (31, 32). 
Summary 
Intravenous  injection  of 0.01  mM  2,4,6-trinitrobenzene  sulfonic  acid-derivatized 
syngeneic  lymphoid  cells  generates  a  Thy-1-positive,  antigen-specific  suppressor  cell 
for contact sensitivity which requires an I-J allogeneic effect to become fully activated. 
It is necessary and sufficient  for the allogeneic effect to be directed  solely against the 
suppressor  cell,  and  once  activated,  the  cell  can  suppress  in  an  H-2-unrestricted 
fashion.  The  results  are  discussed  in  the  framework  of entry  into  the  suppressor 
pathway, the allogeneic effect as a  reflection of normal physiologic processes, and the 
importance of I-J as a  receptor and signal among cells in the suppressor pathway. 
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